LEONID KARKANITSA: Open Payments
NPI 1669435087 · STRATFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 27 payments from 9 companies in 2025. Trend: 2023 $146 · 2024 $983 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $375 |
| Lilly USA, LLC | 2 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $95 |
| PFIZER INC. | 2 | $40 |
| Novo Nordisk Inc | 1 | $29 |
| ABBVIE INC. | 1 | $26 |
| Intra-Sana Laboratories | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Lundbeck LLC | 1 | $19 |
Products named: BREZTRI, MOUNJARO, FARXIGA, Kerendia, FASENRA, REXULTI, PAXLOVID, QULIPTA.
Industry payments across CT — which companies pay providers there.
